Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aileron Therapeutics Inc.

    NASDAQ: ALRN · Real-Time Price · USD
    2.11
    0.18 (9.33%)
    At close: Jan 10, 2025, 10:00 PM

    Aileron Therapeutics Statistics

    Share Statistics

    Aileron Therapeutics has 21.67M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 21.67M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 19.42M

    Failed to Deliver (FTD) Shares

    n/a
    		 20

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 141.21K, so 0.65% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 141.21K

    Short % of Shares Out

    n/a
    		 0.65%

    Short % of Float

    n/a
    		 0.65%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.89 and the forward PE ratio is -1.19. Aileron Therapeutics's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -0.89

    Forward PE

    n/a
    		 -1.19

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 2.04

    P/FCF Ratio

    n/a
    		 -0.71

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Aileron Therapeutics has an Enterprise Value (EV) of -3.24M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 0.21

    EV / EBIT

    n/a
    		 0.16

    EV / FCF

    n/a
    		 0.16

    Financial Position

    The company has a current ratio of 4.17, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 4.17

    Quick Ratio

    n/a
    		 4.17

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -228.43% and Return on Invested Capital is -16.01%.

    Return on Equity

    n/a
    		 -228.43%

    Return on Assets

    n/a
    		 -14.84%

    Return on Invested Capital

    n/a
    		 -16.01%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,048,800

    Employee Count

    n/a
    		 15

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -25.7% in the last 52 weeks. The beta is 2.34, so Aileron Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.34

    52-Week Price Change

    n/a
    		 -25.7%

    50-Day Moving Average

    n/a
    		 2.19

    200-Day Moving Average

    n/a
    		 2.94

    Relative Strength Index (RSI)

    n/a
    		 46.58

    Average Volume (20 Days)

    n/a
    		 101,120

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -119K

    Operating Income

    n/a
    		 -16.28M

    Net Income

    n/a
    		 -15.73M

    EBITDA

    n/a
    		 -15.61M

    EBIT

    n/a
    		 -15.73M

    Earnings Per Share (EPS)

    n/a
    		 -3.42
    Full Income Statement

    Balance Sheet

    The company has 17.31M in cash and 48K in debt, giving a net cash position of 17.27M.

    Cash & Cash Equivalents

    n/a
    		 17.31M

    Total Debt

    n/a
    		 48K

    Net Cash

    n/a
    		 17.27M

    Retained Earnings

    n/a
    		 -288.52M

    Total Assets

    n/a
    		 104.22M

    Working Capital

    n/a
    		 13.03M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -19.81M and capital expenditures 0, giving a free cash flow of -19.81M.

    Operating Cash Flow

    n/a
    		 -19.81M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -19.81M

    FCF Per Share

    n/a
    		 -4.31
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ALRN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -112.16%

    FCF Yield

    n/a
    		 -141.22%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ALRN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 10.74

    Graham Upside

    n/a
    		 409%

    Stock Splits

    The last stock split was on Nov 14, 2022. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Nov 14, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -4.45

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist